Organovo prices $5.25M public offering of common stock and warrants

VivoSim Labs, INC.

Offering of 6.56M units at $0.80/unit; gross proceeds $5.25M before expenses.
Each unit includes one share (or pre-funded warrant) and one common warrant exercisable at $0.80 for 5 years.
Net proceeds ~$4.7M after expenses; expected close May 13, 2024.
Proceeds to be used for working capital, R&D, clinical trials, and general corporate purposes.
JonesTrading acted as exclusive placement agent; securities offered under effective S-1 registration statement.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

VivoSim Labs, INC. entered into Placement Agency Agreement with JonesTrading Institutional Services LLC valued at Cash fee of 5.0% of aggregate gross proceeds raised in the Offering; net proceeds approximately $4.7 (effective 2024-05-08).

Action: entry
Agreement: underwriting
Counterparty: JonesTrading Institutional Services LLC
Value: Cash fee of 5.0% of aggregate gross proceeds raised in the Offering; net proceeds approximately $4.7
Effective: 2024-05-08

Exact text from the filing

In connection with the Offering, the Company entered into a Placement Agency Agreement (the “Placement Agency Agreement”) on May 8, 2024 with JonesTrading Institutional Services LLC (the “Placement Agent”), as the placement agent in connection with the Offering.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

VivoSim Labs, INC. entered into Securities Purchase Agreements with certain purchasers valued at Public offering of 1,562,500 shares of common stock and accompanying Common Warrants at $0.80 per un (effective 2024-05-08).

Action: entry
Agreement: equity purchase
Counterparty: certain purchasers
Value: Public offering of 1,562,500 shares of common stock and accompanying Common Warrants at $0.80 per un
Effective: 2024-05-08

Exact text from the filing

In connection with the Offering, the Company entered into Securities Purchase Agreements (the “Purchase Agreements”) with certain purchasers on May 8, 2024.

View on SEC.gov

290 material agreements filed in the last 30 days. Browse all material agreements →

VivoSim Labs, INC. filing history →

Source: SEC EDGAR

accession 0000950170-24-058805

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.